The DOI matches its Crossref record; 1 of the 1 references it cites were found in a registry or an index.
Urine proteomics: the present and future of measuring urinary protein components in disease
Open accessAbstract
For centuries, physicians have attempted to use the urine for noninvasive assessment of disease. Today, urinalysis, in particular the measurement of proteinuria, underpins the routine assessment of patients with renal disease. More sophisticated methods for assessing specific urinary protein losses have emerged; however, albumin is still the principal urinary protein measured. Changes in the pattern of urinary protein excretion are not necessarily restricted to nephrourological disease; for instance, the appearance of beta-human chorionic gonadotropin in the urine of pregnant women is the basis for all commercially available pregnancy kits. Similarly, microalbuminuria is a clinically important marker not only of early diabetic nephropathy but also of concomitant cardiovascular disease. With the emergence of newer technologies, in particular mass spectrometry, it has become possible to study urinary protein excretion in even more detail. A variety of techniques have been used both to characterize the normal complement of urinary proteins and also to identify proteins and peptides that may facilitate earlier detection of disease, improve assessment of prognosis and allow closer monitoring of response to therapy. Such proteomics-based approaches hold great promise as the basis for new diagnostic tests and as the means to better understand disease pathogenesis. In this review, we summarize the currently available methods for urinary protein analysis and describe the newer approaches being taken to identify urinary biomarkers.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Roberts, W. L., Calcote, C. B., Cook, C. B., Gordon, D. L., Moore, M. L., Moore, S., Scheer, W. D., & Snazelle, B. A. (1998) · Clinica Chimica Acta · doi:10.1016/s0009-8981(98)00021-7 · Cited by 26
Cited by
Molecular Signatures of Obstructive Sleep Apnea in Adults: A Review and Perspective
Arnardottir, E. S., Mackiewicz, M., Gislason, T., Teff, K. L., & Pack, A. I. (2009) · Sleep · doi:10.1093/sleep/32.4.447 · Cited by 345
VEGF signalling inhibition-induced proteinuria: Mechanisms, significance and management
Izzedine, H., Massard, C., Spano, J. P., Goldwasser, F., Khayat, D., & Soria, J. C. (2010) · European Journal of Cancer · doi:10.1016/j.ejca.2009.11.001 · Cited by 332
Urine proteome of COVID-19 patients
(2020) · doi:10.1016/j.urine.2021.02.001 · Cited by 68
Metadata
- Authors
- Barratt, J., & Topham, P.
- Venue
- Canadian Medical Association Journal
- Publisher
- CMA Joule Inc.
- Published
- 2007-08-14
- Volume
- 177
- Issue
- 4
- Pages
- 361-368
- ISSN
- 0820-3946 (ISSN-L)
- 1488-2329
- OpenAlex
- W2071323450
- Cited by
- 222
- References
- 1
- FWCI
- 5.66
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Urine proteomics: the present and future of measuring urinary protein components in disease. https://app.cochat.ai/papers/10.1503/cmaj.061590
- The paper
- Barratt, J., & Topham, P. (2007). Urine proteomics: the present and future of measuring urinary protein components in disease. Canadian Medical Association Journal. https://doi.org/10.1503/cmaj.061590
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.